Abstract:
Distribution of pharmaceutical products is an important activity in the integrated supply-chain
management. Feeble points in the distribution processes of pharmaceutical products provide viable
ground for counterfeit, illegally imported, stolen and substandard medicines to enter the supply
chain. To maintain the original quality of pharmaceutical products, every party involved in the
distribution chain should comply with the applicable practices, legislation and regulations. Each
activity in the distribution of pharmaceutical products should be carried out according to the
principles of Good Manufacturing Practice (GMP), good storage practices (GSP) and good
distribution practices (GDP).